PHTHALAZINONE COMPOUNDS AS PARP7 INHIBITORS

The present disclosure relates to phthalazinone compounds and related compounds and their use in treating a disease or condition responsive to inhibition of PARP7. La présente divulgation concerne des composés de phtalazinone et des composés associés ainsi que leur utilisation dans le traitement d&#...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ZHOU, Yuchen, COHEN, Michael S, RODRIGUEZ, Kelsie M, PELLETIER, Guillaume, SPELLMEYER, David C, NG, Raymond A, DENG, Jinxia N, SANDERSON, Daniel J, WINTER, Dana K, NOVOSELTSEVA, Polina, LAPOINTE, David, SUNDALAM, Sunil K, JOHNSON, Michael G
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator ZHOU, Yuchen
COHEN, Michael S
RODRIGUEZ, Kelsie M
PELLETIER, Guillaume
SPELLMEYER, David C
NG, Raymond A
DENG, Jinxia N
SANDERSON, Daniel J
WINTER, Dana K
NOVOSELTSEVA, Polina
LAPOINTE, David
SUNDALAM, Sunil K
JOHNSON, Michael G
description The present disclosure relates to phthalazinone compounds and related compounds and their use in treating a disease or condition responsive to inhibition of PARP7. La présente divulgation concerne des composés de phtalazinone et des composés associés ainsi que leur utilisation dans le traitement d'une maladie ou d'une affection en réponse à l'inhibition de PARP7.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2023192989A3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2023192989A3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2023192989A33</originalsourceid><addsrcrecordid>eNrjZNAO8AjxcPRxjPL08_dzVXD29w3wD_VzCVZwDFYIcAwKMFfw9PPwdPIM8Q8K5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgZGxoaWRpYWlo7GxsSpAgAi6SYm</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PHTHALAZINONE COMPOUNDS AS PARP7 INHIBITORS</title><source>esp@cenet</source><creator>ZHOU, Yuchen ; COHEN, Michael S ; RODRIGUEZ, Kelsie M ; PELLETIER, Guillaume ; SPELLMEYER, David C ; NG, Raymond A ; DENG, Jinxia N ; SANDERSON, Daniel J ; WINTER, Dana K ; NOVOSELTSEVA, Polina ; LAPOINTE, David ; SUNDALAM, Sunil K ; JOHNSON, Michael G</creator><creatorcontrib>ZHOU, Yuchen ; COHEN, Michael S ; RODRIGUEZ, Kelsie M ; PELLETIER, Guillaume ; SPELLMEYER, David C ; NG, Raymond A ; DENG, Jinxia N ; SANDERSON, Daniel J ; WINTER, Dana K ; NOVOSELTSEVA, Polina ; LAPOINTE, David ; SUNDALAM, Sunil K ; JOHNSON, Michael G</creatorcontrib><description>The present disclosure relates to phthalazinone compounds and related compounds and their use in treating a disease or condition responsive to inhibition of PARP7. La présente divulgation concerne des composés de phtalazinone et des composés associés ainsi que leur utilisation dans le traitement d'une maladie ou d'une affection en réponse à l'inhibition de PARP7.</description><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20231123&amp;DB=EPODOC&amp;CC=WO&amp;NR=2023192989A3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20231123&amp;DB=EPODOC&amp;CC=WO&amp;NR=2023192989A3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ZHOU, Yuchen</creatorcontrib><creatorcontrib>COHEN, Michael S</creatorcontrib><creatorcontrib>RODRIGUEZ, Kelsie M</creatorcontrib><creatorcontrib>PELLETIER, Guillaume</creatorcontrib><creatorcontrib>SPELLMEYER, David C</creatorcontrib><creatorcontrib>NG, Raymond A</creatorcontrib><creatorcontrib>DENG, Jinxia N</creatorcontrib><creatorcontrib>SANDERSON, Daniel J</creatorcontrib><creatorcontrib>WINTER, Dana K</creatorcontrib><creatorcontrib>NOVOSELTSEVA, Polina</creatorcontrib><creatorcontrib>LAPOINTE, David</creatorcontrib><creatorcontrib>SUNDALAM, Sunil K</creatorcontrib><creatorcontrib>JOHNSON, Michael G</creatorcontrib><title>PHTHALAZINONE COMPOUNDS AS PARP7 INHIBITORS</title><description>The present disclosure relates to phthalazinone compounds and related compounds and their use in treating a disease or condition responsive to inhibition of PARP7. La présente divulgation concerne des composés de phtalazinone et des composés associés ainsi que leur utilisation dans le traitement d'une maladie ou d'une affection en réponse à l'inhibition de PARP7.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNAO8AjxcPRxjPL08_dzVXD29w3wD_VzCVZwDFYIcAwKMFfw9PPwdPIM8Q8K5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgZGxoaWRpYWlo7GxsSpAgAi6SYm</recordid><startdate>20231123</startdate><enddate>20231123</enddate><creator>ZHOU, Yuchen</creator><creator>COHEN, Michael S</creator><creator>RODRIGUEZ, Kelsie M</creator><creator>PELLETIER, Guillaume</creator><creator>SPELLMEYER, David C</creator><creator>NG, Raymond A</creator><creator>DENG, Jinxia N</creator><creator>SANDERSON, Daniel J</creator><creator>WINTER, Dana K</creator><creator>NOVOSELTSEVA, Polina</creator><creator>LAPOINTE, David</creator><creator>SUNDALAM, Sunil K</creator><creator>JOHNSON, Michael G</creator><scope>EVB</scope></search><sort><creationdate>20231123</creationdate><title>PHTHALAZINONE COMPOUNDS AS PARP7 INHIBITORS</title><author>ZHOU, Yuchen ; COHEN, Michael S ; RODRIGUEZ, Kelsie M ; PELLETIER, Guillaume ; SPELLMEYER, David C ; NG, Raymond A ; DENG, Jinxia N ; SANDERSON, Daniel J ; WINTER, Dana K ; NOVOSELTSEVA, Polina ; LAPOINTE, David ; SUNDALAM, Sunil K ; JOHNSON, Michael G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2023192989A33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ZHOU, Yuchen</creatorcontrib><creatorcontrib>COHEN, Michael S</creatorcontrib><creatorcontrib>RODRIGUEZ, Kelsie M</creatorcontrib><creatorcontrib>PELLETIER, Guillaume</creatorcontrib><creatorcontrib>SPELLMEYER, David C</creatorcontrib><creatorcontrib>NG, Raymond A</creatorcontrib><creatorcontrib>DENG, Jinxia N</creatorcontrib><creatorcontrib>SANDERSON, Daniel J</creatorcontrib><creatorcontrib>WINTER, Dana K</creatorcontrib><creatorcontrib>NOVOSELTSEVA, Polina</creatorcontrib><creatorcontrib>LAPOINTE, David</creatorcontrib><creatorcontrib>SUNDALAM, Sunil K</creatorcontrib><creatorcontrib>JOHNSON, Michael G</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ZHOU, Yuchen</au><au>COHEN, Michael S</au><au>RODRIGUEZ, Kelsie M</au><au>PELLETIER, Guillaume</au><au>SPELLMEYER, David C</au><au>NG, Raymond A</au><au>DENG, Jinxia N</au><au>SANDERSON, Daniel J</au><au>WINTER, Dana K</au><au>NOVOSELTSEVA, Polina</au><au>LAPOINTE, David</au><au>SUNDALAM, Sunil K</au><au>JOHNSON, Michael G</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PHTHALAZINONE COMPOUNDS AS PARP7 INHIBITORS</title><date>2023-11-23</date><risdate>2023</risdate><abstract>The present disclosure relates to phthalazinone compounds and related compounds and their use in treating a disease or condition responsive to inhibition of PARP7. La présente divulgation concerne des composés de phtalazinone et des composés associés ainsi que leur utilisation dans le traitement d'une maladie ou d'une affection en réponse à l'inhibition de PARP7.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO2023192989A3
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title PHTHALAZINONE COMPOUNDS AS PARP7 INHIBITORS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T11%3A05%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ZHOU,%20Yuchen&rft.date=2023-11-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2023192989A3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true